Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12619001082190Phase 4Recruiting
Phase 4 trial of venlafaxine and duloxetine in knee osteoarthritis (OA) (2 arms), sponsored by Waitematā District Health Board. Primary endpoint: Change in Brief Pain Inventory average pain rating. Started Sep 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12619001082190.